These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31133457)

  • 1. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Bally L; Gubler P; Thabit H; Hartnell S; Ruan Y; Wilinska ME; Evans ML; Semmo M; Vogt B; Coll AP; Stettler C; Hovorka R
    Kidney Int; 2019 Sep; 96(3):593-596. PubMed ID: 31133457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term fully closed-loop insulin delivery using faster insulin aspart compared with standard insulin aspart in type 2 diabetes.
    Bally L; Herzig D; Ruan Y; Wilinska ME; Semmo M; Vogt A; Wertli MM; Vogt B; Stettler C; Hovorka R
    Diabetes Obes Metab; 2019 Dec; 21(12):2718-2722. PubMed ID: 31464063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.
    Bally L; Thabit H; Hartnell S; Andereggen E; Ruan Y; Wilinska ME; Evans ML; Wertli MM; Coll AP; Stettler C; Hovorka R
    N Engl J Med; 2018 Aug; 379(6):547-556. PubMed ID: 29940126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial.
    Boughton CK; Bally L; Martignoni F; Hartnell S; Herzig D; Vogt A; Wertli MM; Wilinska ME; Evans ML; Coll AP; Stettler C; Hovorka R
    Lancet Diabetes Endocrinol; 2019 May; 7(5):368-377. PubMed ID: 30935872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study.
    Kumareswaran K; Thabit H; Leelarathna L; Caldwell K; Elleri D; Allen JM; Nodale M; Wilinska ME; Evans ML; Hovorka R
    Diabetes Care; 2014; 37(5):1198-203. PubMed ID: 24026542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial.
    Thabit H; Hartnell S; Allen JM; Lake A; Wilinska ME; Ruan Y; Evans ML; Coll AP; Hovorka R
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):117-124. PubMed ID: 27836235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
    Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
    Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Wilinska ME; Hovorka R
    Biomed Eng Online; 2015 Mar; 14():19. PubMed ID: 25889091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial.
    Boughton CK; Tripyla A; Hartnell S; Daly A; Herzig D; Wilinska ME; Czerlau C; Fry A; Bally L; Hovorka R
    Nat Med; 2021 Aug; 27(8):1471-1476. PubMed ID: 34349267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of fully closed-loop insulin delivery for inpatients with diabetes: Real-world outcomes.
    Boughton CK; Hartnell S; Hobday N; Lake A; Davenport K; Daly A; Ward C; Taylor C; Hovorka R; Bansiya V
    Diabet Med; 2023 Jun; 40(6):e15092. PubMed ID: 36947090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes.
    Herzig D; Dehais J; Prost JC; Nakas CT; Stettler C; Bally L; Hovorka R
    Diabetes Technol Ther; 2020 Sep; 22(9):691-696. PubMed ID: 31999478
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial.
    Herzig D; Suhner S; Roos J; Schürch D; Cecchini L; Nakas CT; Weiss S; Kadner A; Kocher GJ; Guensch DP; Wilinska ME; Raabe A; Siebenrock KA; Beldi G; Gloor B; Hovorka R; Vogt AP; Bally L
    Diabetes Care; 2022 Sep; 45(9):2076-2083. PubMed ID: 35880252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring and closed-loop systems.
    Hovorka R
    Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.